Plasma microRNA‐192‐5p can predict the response to neoadjuvant chemotherapy and prognosis in esophageal cancer

Esophageal cancer (EC) is the sixth leading cause of cancer‐related death worldwide. Recently, neoadjuvant chemotherapy (NAC) before curative surgery has become a standard treatment for clinical stage II or III EC patients. Some EC patients receive a complete response (CR) by NAC; thus, curative sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Furuke, Hirotaka, Konishi, Hirotaka, Arita, Tomohiro, Kataoka, Satoshi, Shibamoto, Jun, Takabatake, Kazuya, Takaki, Wataru, Shimizu, Hiroki, Yamamoto, Yusuke, Komatsu, Shuhei, Shiozaki, Atsushi, Fujiwara, Hitoshi, Otsuji, Eigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067423/
https://www.ncbi.nlm.nih.gov/pubmed/36533956
http://dx.doi.org/10.1111/cas.15703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067423/
https://www.ncbi.nlm.nih.gov/pubmed/36533956
http://dx.doi.org/10.1111/cas.15703

Ejemplares similares